Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism

Clinical trial NCT00463346 · COMPLETED

Trial details

NCT number: NCT00463346
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alcohol Dependence Schizophrenia

Start date: 2006-09-01
Primary completion: 2015-07-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.